Showing results (131-140 of 179) with videos related to

Sort By:
Pageof 18
Plos One|May 19, 2012
Structural insights into human peroxisome proliferator activated receptor delta (PPAR-delta) selective ligand bindingFernanda A H Batista, Daniela B B Trivella, Amanda Bernardes, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 4, 2014
Recruited metastasis suppressor NM23-H2 attenuates expression and activity of peroxisome proliferator-activated receptor δ (PPARδ) in human cholangiocarcinomaFang He, J Philippe York, Sherilyn Gordon Burroughs, et al.
The Journal of Biological Chemistry|May 3, 2002
Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expressionMeng-Min Liu, Chris Albanese, Carol M Anderson, et al.
Veterinary Research|November 3, 2012
The interpretation of disease phenotypes to identify TSE strains following murine bioassay: characterisation of classical scrapieKaty E Beck, Christopher M Vickery, Richard Lockey, et al.
The Journal of Biological Chemistry|May 16, 2012
GQ-16, a novel peroxisome proliferator-activated receptor γ (PPARγ) ligand, promotes insulin sensitization without weight gainAngélica A Amato, Senapathy Rajagopalan, Jean Z Lin, et al.
International Journal of Law and Psychiatry|September 5, 2020
Key components of supporting and assessing decision making abilityPaul Webb, Gavin Davidson, Rosalie Edge, et al.
Health & Social Care in the Community|February 25, 2020
Service users' experiences and views of support for decision-makingPaul Webb, Gavin Davidson, Rosalie Edge, et al.
Research Involvement and Engagement|December 8, 2022
Peer researchers' experiences of a co-produced research project on supported decision-makingPaul Webb, David Falls, Fionnuala Keenan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2003
Selective thyroid hormone receptor-beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liabilityGary J Grover, Karin Mellström, Liu Ye, et al.
Plos One|June 18, 2014
The human orphan nuclear receptor tailless (TLX, NR2E1) is druggableCindy Benod, Rosa Villagomez, Carly S Filgueira, et al.
Pageof 18